Loading company…
PuREC Co., Ltd. develops and sells high-purity mesenchymal stem cells for clinical use in Japan and the United States.
Founded in 2016 in Izumo-shi, Japan, PuREC Co., Ltd. cultivates high-purity mesenchymal stem cells under the Rapidly Expanding Cells (REC) brand. It sells them to hospitals and research institutions for clinical use, along with contract cell separation and cultivation services. In March 2022 it raised JPY 700 million in Series C funding from investors including Gogin Capital, Mochida Pharmaceutical, and San-in Godo Bank. The current CEO is Hide Takahashi.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in